Surrozen, Inc./DE

Churchill Capital Corp VII, trading under the ticker CHFW, is a blank-check company sponsored by Churchill Capital Company VII LLC, the vehicle associated with veteran dealmaker Michael Klein. The SPAC completed its initial public offering in 2021, targeting the biotechnology and life sciences sector. A Form 8-K filed May 14, 2026, under accession number 0001193125-26-224037 reflects a material development in the company's lifecycle, with the registrant name updated to Surrozen, Inc., a Delaware-incorporated clinical-stage biopharmaceutical company focused on Wnt signaling pathway therapeutics for tissue and organ repair. Sign up for a full SpacDesk subscription to access complete filing histories, sponsor profiles, and deal analytics for CHFW and every active SPAC in our coverage universe.